羧酸取代塞来昔布异构体作为潜在抗炎剂的设计、合成和评价

IF 6 2区 医学 Q1 CHEMISTRY, MEDICINAL European Journal of Medicinal Chemistry Pub Date : 2025-01-17 DOI:10.1016/j.ejmech.2025.117286
Zi-Jie Song, Xiao-Fei Wu, Zhi-Ya Zhou, Jing-Jing Zhang, P.A.N. Yan-Yan, Xue Dong, Xuan Pang, Ya-Ping Xie, Juan Sun, Yu Zhang, Jie Qin
{"title":"羧酸取代塞来昔布异构体作为潜在抗炎剂的设计、合成和评价","authors":"Zi-Jie Song, Xiao-Fei Wu, Zhi-Ya Zhou, Jing-Jing Zhang, P.A.N. Yan-Yan, Xue Dong, Xuan Pang, Ya-Ping Xie, Juan Sun, Yu Zhang, Jie Qin","doi":"10.1016/j.ejmech.2025.117286","DOIUrl":null,"url":null,"abstract":"A library comprising twenty-four isosteric derivatives of celecoxib substituted with carboxylic acid (labeled as <strong>5a</strong>-<strong>5x</strong>), was synthesized and characterized through <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS, and elemental analysis. Molecular docking studies revealed that all compounds successfully docked into the binding pocket of COX-2, and the introduction of carboxyl group enhances the interaction between the derivatives and COX-2. The compounds were further evaluated for cell toxicity, and <em>in vitro</em> anti-inflammatory activity. Notably, compound <strong>5l</strong> exhibited significant inhibition of both COX-2 and NO release <em>in vitro</em> in comparison to the standard compound, displaying the highest selectivity towards the COX-2 enzyme (SI = 295.9) in comparison to celecoxib (SI = 261.3). <strong>5l</strong> also exhibited the most potent anti-inflammatory activity and safety (ulcer index = 5.2) <em>in vivo</em> comparable to celecoxib at the same concentration. Through the molecular modeling and dynamics analysis, it was observed that compound <strong>5l</strong> effectively stabilized within the active binding site of COX-2 through strong hydrogen bond interactions, and through the ADMET studies investigated the physiochemical properties and drug-likeliness behavior of compound <strong>5l</strong>. In conclusion, compound <strong>5l</strong> demonstrated to be a potential selective COX-2 anti-inflammatory candidate with reduced gastrointestinal risks.","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"83 1","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Design, synthesis, and evaluation of carboxylic acid-substituted celecoxib isosteres as potential anti-inflammatory agents\",\"authors\":\"Zi-Jie Song, Xiao-Fei Wu, Zhi-Ya Zhou, Jing-Jing Zhang, P.A.N. Yan-Yan, Xue Dong, Xuan Pang, Ya-Ping Xie, Juan Sun, Yu Zhang, Jie Qin\",\"doi\":\"10.1016/j.ejmech.2025.117286\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A library comprising twenty-four isosteric derivatives of celecoxib substituted with carboxylic acid (labeled as <strong>5a</strong>-<strong>5x</strong>), was synthesized and characterized through <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS, and elemental analysis. Molecular docking studies revealed that all compounds successfully docked into the binding pocket of COX-2, and the introduction of carboxyl group enhances the interaction between the derivatives and COX-2. The compounds were further evaluated for cell toxicity, and <em>in vitro</em> anti-inflammatory activity. Notably, compound <strong>5l</strong> exhibited significant inhibition of both COX-2 and NO release <em>in vitro</em> in comparison to the standard compound, displaying the highest selectivity towards the COX-2 enzyme (SI = 295.9) in comparison to celecoxib (SI = 261.3). <strong>5l</strong> also exhibited the most potent anti-inflammatory activity and safety (ulcer index = 5.2) <em>in vivo</em> comparable to celecoxib at the same concentration. Through the molecular modeling and dynamics analysis, it was observed that compound <strong>5l</strong> effectively stabilized within the active binding site of COX-2 through strong hydrogen bond interactions, and through the ADMET studies investigated the physiochemical properties and drug-likeliness behavior of compound <strong>5l</strong>. In conclusion, compound <strong>5l</strong> demonstrated to be a potential selective COX-2 anti-inflammatory candidate with reduced gastrointestinal risks.\",\"PeriodicalId\":314,\"journal\":{\"name\":\"European Journal of Medicinal Chemistry\",\"volume\":\"83 1\",\"pages\":\"\"},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2025-01-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ejmech.2025.117286\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejmech.2025.117286","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

合成了24个羧酸取代塞来昔布等构衍生物(标记为5a-5x),并通过1H NMR、13C NMR、HRMS和元素分析对其进行了表征。分子对接研究表明,所有化合物都成功地对接到COX-2的结合口袋中,羧基的引入增强了衍生物与COX-2的相互作用。进一步评价了这些化合物的细胞毒性和体外抗炎活性。值得注意的是,与标准化合物相比,化合物5l对COX-2酶和NO的体外释放均有显著的抑制作用,与塞来昔布(SI = 261.3)相比,化合物5l对COX-2酶的选择性最高(SI = 295.9)。5l在体内也表现出与塞来昔布相同浓度下最有效的抗炎活性和安全性(溃疡指数= 5.2)。通过分子建模和动力学分析,观察到化合物5l通过强氢键相互作用有效稳定在COX-2的活性结合位点内,并通过ADMET研究考察了化合物5l的理化性质和药物似然行为。总之,化合物5l被证明是一种潜在的选择性COX-2抗炎候选物,具有降低胃肠道风险的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Design, synthesis, and evaluation of carboxylic acid-substituted celecoxib isosteres as potential anti-inflammatory agents
A library comprising twenty-four isosteric derivatives of celecoxib substituted with carboxylic acid (labeled as 5a-5x), was synthesized and characterized through 1H NMR, 13C NMR, HRMS, and elemental analysis. Molecular docking studies revealed that all compounds successfully docked into the binding pocket of COX-2, and the introduction of carboxyl group enhances the interaction between the derivatives and COX-2. The compounds were further evaluated for cell toxicity, and in vitro anti-inflammatory activity. Notably, compound 5l exhibited significant inhibition of both COX-2 and NO release in vitro in comparison to the standard compound, displaying the highest selectivity towards the COX-2 enzyme (SI = 295.9) in comparison to celecoxib (SI = 261.3). 5l also exhibited the most potent anti-inflammatory activity and safety (ulcer index = 5.2) in vivo comparable to celecoxib at the same concentration. Through the molecular modeling and dynamics analysis, it was observed that compound 5l effectively stabilized within the active binding site of COX-2 through strong hydrogen bond interactions, and through the ADMET studies investigated the physiochemical properties and drug-likeliness behavior of compound 5l. In conclusion, compound 5l demonstrated to be a potential selective COX-2 anti-inflammatory candidate with reduced gastrointestinal risks.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
11.70
自引率
9.00%
发文量
863
审稿时长
29 days
期刊介绍: The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.
期刊最新文献
Recent Advances in The Therapeutic Insights of Thiazole Scaffolds as Acetylcholinesterase Inhibitors Cytotoxic pyrrole-based gold(III) chelates target human topoisomerase II as dual-mode inhibitors and interact with human serum albumin Corrigendum to “Applying molecular hybridization to design a new class of pyrazolo[3,4-d] pyrimidines as Src inhibitors active in hepatocellular carcinoma” [Eur. J. Med. Chem. 280 (2024) 116929] Design, Synthesis and Evaluation of Diarylidenyl Piperidone-Ligated Platinum (IV) Complexes as Chemoimmunotherapeutic Agents Optimization of pyrazole/1,2,4-triazole as dual EGFR/COX-2 inhibitors: Design, synthesis, anticancer potential, apoptosis induction and cell cycle analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1